These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25463742)

  • 1. Cardiac contractility modulation: the next cardiac resynchronization therapy or another renal sympathetic denervation?
    Mentz RJ; Butler J
    J Card Fail; 2015 Jan; 21(1):24-6. PubMed ID: 25463742
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal sympathetic denervation: A potential alternative strategy for managing patients with heart failure.
    Lu Y; Zhang L; Zhou X; Tang B
    Int J Cardiol; 2015 Dec; 201():140-1. PubMed ID: 26298357
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in the elderly: a realistic option for an increasing population?
    António N; Elvas L; Gonçalves L; Providência LA
    Int J Cardiol; 2012 Feb; 155(1):49-51. PubMed ID: 21334076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Finding pieces of the puzzle of nonresponse to cardiac resynchronization therapy.
    Gorcsan J
    Circulation; 2011 Jan; 123(1):10-2. PubMed ID: 21173347
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of left ventricular reverse remodeling induced by cardiac contractility modulation and cardiac resynchronization therapy in heart failure patients with different QRS durations.
    Zhang Q; Chan YS; Liang YJ; Fang F; Lam YY; Chan CP; Lee AP; Chan KC; Wu EB; Yu CM
    Int J Cardiol; 2013 Aug; 167(3):889-93. PubMed ID: 22330007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure.
    Böhm M; Ewen S; Linz D; Reil JC; Schirmer SH; Ukena C; Mahfoud F
    EuroIntervention; 2013 May; 9 Suppl R():R122-6. PubMed ID: 23732144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and prognostic role of pressure-volume relationship in the identification of responders to cardiac resynchronization therapy.
    Ciampi Q; Pratali L; Citro R; Villari B; Picano E; Sicari R
    Am Heart J; 2010 Nov; 160(5):906-14. PubMed ID: 21095279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
    Kadish A; Nademanee K; Volosin K; Krueger S; Neelagaru S; Raval N; Obel O; Weiner S; Wish M; Carson P; Ellenbogen K; Bourge R; Parides M; Chiacchierini RP; Goldsmith R; Goldstein S; Mika Y; Burkhoff D; Abraham WT
    Am Heart J; 2011 Feb; 161(2):329-337.e1-2. PubMed ID: 21315216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autonomic modulation for the management of patients with chronic heart failure.
    Schwartz PJ; La Rovere MT; De Ferrari GM; Mann DL
    Circ Heart Fail; 2015 May; 8(3):619-28. PubMed ID: 25991804
    [No Abstract]   [Full Text] [Related]  

  • 10. Interventional and device-based autonomic modulation in heart failure.
    Shen MJ; Zipes DP
    Heart Fail Clin; 2015 Apr; 11(2):337-48. PubMed ID: 25834979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac contractility modulation in patients with advanced heart failure.
    Kahwash R; Burkhoff D; Abraham WT
    Expert Rev Cardiovasc Ther; 2013 May; 11(5):635-45. PubMed ID: 23621145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronisation therapy for heart failure with narrow or normal QRS.
    Yip GW; Fung JW
    Heart; 2011 Jul; 97(13):1029-31. PubMed ID: 21343170
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding the indications for cardiac resynchronisation therapy.
    Yu CM; Fang F
    Heart; 2014 Mar; 100(6):447-9. PubMed ID: 23846612
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac resynchronization: what's next?
    Leclercq C
    Arch Cardiovasc Dis; 2012; 105(6-7):335-7. PubMed ID: 22800717
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal denervation and heart failure.
    Böhm M; Ewen S; Kindermann I; Linz D; Ukena C; Mahfoud F
    Eur J Heart Fail; 2014 Jun; 16(6):608-13. PubMed ID: 24644008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New developments in cardiac resynchronization therapy.
    Sankaranarayanan R; Visweswariah R; Fox DJ
    Br J Hosp Med (Lond); 2013 Sep; 74(9):503-9. PubMed ID: 24022551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cardiac resynchronization therapy on myocardial contractile reserve during exercise.
    Valzania C; Gadler F; Boriani G; Eriksson MJ
    Eur J Heart Fail; 2011 Apr; 13(4):406-11. PubMed ID: 21205782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of renal denervation on the development of post-myocardial infarction heart failure and cardiac autonomic nervous system in rats.
    Hu J; Yan Y; Zhou Q; Ji M; Niu C; Hou Y; Ge J
    Int J Cardiol; 2014 Apr; 172(3):e414-6. PubMed ID: 24485639
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (DenervatIon of the renAl Sympathetic nerves in hearT failure with nOrmal Lv Ejection fraction) trial.
    Verloop WL; Beeftink MM; Nap A; Bots ML; Velthuis BK; Appelman YE; Cramer MJ; Agema WR; Scholtens AM; Doevendans PA; Allaart CP; Voskuil M
    Eur J Heart Fail; 2013 Dec; 15(12):1429-37. PubMed ID: 23883653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
    Giallauria F; Vigorito C; Piepoli MF; Stewart Coats AJ
    Int J Cardiol; 2014 Aug; 175(2):352-7. PubMed ID: 24975782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.